JP2000159681A - Extract from grape seed and its use - Google Patents

Extract from grape seed and its use

Info

Publication number
JP2000159681A
JP2000159681A JP11124735A JP12473599A JP2000159681A JP 2000159681 A JP2000159681 A JP 2000159681A JP 11124735 A JP11124735 A JP 11124735A JP 12473599 A JP12473599 A JP 12473599A JP 2000159681 A JP2000159681 A JP 2000159681A
Authority
JP
Japan
Prior art keywords
extract
grape seed
organic solvent
tyrosinase
active ingredient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP11124735A
Other languages
Japanese (ja)
Inventor
Yun-Hyon Lee
リー,ユン−ヒョン
Sun-Je Lee
リー,スン−ジェ
Je-Kwong Jan
ジャン,ジェ−クウォン
Shi-Yong Park
パク,シ−ヨン
Hyun-Kuk Lee
リー,ヒュン−クク
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Haitai Confectionery Co Ltd
Original Assignee
Haitai Confectionery Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haitai Confectionery Co Ltd filed Critical Haitai Confectionery Co Ltd
Publication of JP2000159681A publication Critical patent/JP2000159681A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L3/00Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
    • A23L3/34Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
    • A23L3/3454Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
    • A23L3/3463Organic compounds; Microorganisms; Enzymes
    • A23L3/3472Compounds of undetermined constitution obtained from animals or plants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/87Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/02Antioxidant
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/318Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

PROBLEM TO BE SOLVED: To obtain an extract from grape seeds which shows inhibitory activity against tyrosinase and is useful as a tyrosinase inhibitor effectively controlling melanin by extracting grape seeds with water and/or an organic solvent. SOLUTION: This extract is obtained by extracting grape seeds with water and/or an organic solvent. As the organic solvent, ethanol, methanol or acetone is favorable. Further, the powder of grape seeds is preferably extracted with an organic solvent of a concentration of 70-80 % under the condition of hot water or heating. This extract is preferably administrated at a dosage of 25-200 mg a day per an adult. This extract may be used as an active ingredient in cosmetics which control melanin formation, prevent skins from aging, protect skins and possess skin-whitening function, an active ingredient in pharmaceutical compositions for treating hyperpigmentation including stain, freckle, spot or superpigmentation in gravidism or an active ingredient in food additives for controlling the browning of foods including fruits, vegetables and perishables.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【発明の属する技術分野】本発明はチロシナーゼ(tyro
sinase)阻害活性を有する葡萄の種の抽出物、及び用途
に関する。より詳しくは、本発明は水、エタノール、メ
タノールまたはアセトンを使用して熱水または加熱条件
から製造した美白化粧料、過剰色素症の治療剤及び食品
の褐変抑制剤として使われる葡萄の種の抽出物に関す
る。
TECHNICAL FIELD The present invention relates to tyrosinase (tyro)
ginseng extract having inhibitory activity and uses. More specifically, the present invention relates to the extraction of grape seeds used as whitening cosmetics, therapeutic agents for hyperpigmentation and food browning inhibitors prepared from hot water or heating conditions using water, ethanol, methanol or acetone. About things.

【0001】[0001]

【従来の技術】メラニン(melanin )は黒い色素とタン
パク質の複合体形態を有するフェノル類の生物高分子物
質として、リンゴ、ジャガイモ、バナナの切った表面が
空気中に晒されるとき発生する褐変または動物の外皮、
羽、皮膚、髪、目などから観察することができる。しか
し、メラニンが過剰生産される場合、皮膚にシミ、ソバ
カスなどが形成され皮膚老化を促進し、皮膚癌も誘発す
ることができるし、また食品においては野菜、果物、生
鮮などの品質を低下させる作用もある。メラニンは主に
チロシナーゼ(tyrosinase)の作用により生合成される
ものと報告されている。チロシナーゼは銅(Cu)と結合
した酵素として、動物、植物、微生物及び人などに広く
分布されていて、モノヒドロキシまたはジヒドロキシフ
ェニルアラニン(dihydroxy −phenylalanine, DOPA )
などのフェニル化合物で好気的酸化を促進させるし、紫
外線に激しく晒された皮膚にメラニントーズ(melanint
orth)を沈着させ皮膚の老化または損傷を誘発させる作
用がある。また、野菜または果実類においてもチロシナ
ーゼなどのようなポリフェノルオキシダーゼ(polyphen
ol oxidase)が食品の褐変化現像を来す。チロシナーゼ
により生成が触媒される動物メラニンは黄色−赤褐色の
フェオメラニン(pheomelanin )と褐色−黒色のオイメ
ラニン(eumelanin )に区分される。このようなメラニ
ンの合成課程はチロシナーゼの活性程度に従いL−チロ
シンからL−3,4−ジヒドロキシ−フェニルアラニン
(DOPA, L−3, 4−dihydroxy −phenylalanine )にヒ
ドロキシ化され、さらにDOPAからドパキノン(dopaquin
one )に酸化されるし、ドパキノンはロイコクロム(le
ucochrome )に酸化されるし、ロイコクロムの酸化によ
りドパクロム(dopachrome)が生成されるし、ドパクロ
ムはさらに5,6−ジヒドロキシインドール(DHI, 5,
6 −dihydroxyindole )に転換されるし、このジヒドロ
キシインドールが酸化的に重合されタンパク質と最終的
に結合されるものと構成される。生体内にはドパクロム
がDHIに転換される経路以外にもドパクロムトートメラ
ゼ(dopachrome tautomerase)が作用して5,6−ジヒ
ドロキシインドールカルボキシ酸(DHICA, 5, 6 −dihy
droxyindole carboxylic acid )に転換される新しい経
路があることも報告されている。メラニンの生合成代謝
は皮膚癌と関連して最近集中的に研究されているし、そ
れから多様なメラニン生成阻害剤などが開発され医薬品
産業で皮膚疾患治療剤、化粧品産業でシミ、ソバカスな
どを予防及び治療する皮膚美白剤または食品産業で褐変
防止剤などとして適用されている。また、最近には環境
問題と関連してその需要が急激に増加している。いまま
でメラニン生成阻害剤の研究は、主にチロシナーゼ阻害
剤を開発する方向に集中されてきて、代表的なチロシナ
ーゼ阻害剤はチロシナーゼ活性部位の銅イオンに対する
キレート形成物質、キノン(quinone )類をフェノル類
に還元させるアスコルビン酸(ascorbic acid )などの
還元剤そしてチロシナーゼ自体を変成させるビスルファ
イト(bisulfites)製剤などをあげることができる。こ
のようにチロシナーゼ阻害剤が多様な美白剤などに開発
され現在使用されているが、さまざまな問題点も同時に
提起されている。実際にシミ、ソバカス、斑点及び妊娠
期過色素沈着(hyperpigmentation )のような過剰色素
症治療に局部的に使用されている4−ヒドロキシアニソ
ール(4 −hydroxyanisole)及びヒドロキノン(hydroq
uinone)などは強力なメラニン生成阻害活性はあるが同
時に色素細胞の変成または致死を誘発し細胞本来の機能
を損傷させるなどの副作用を表している。特にヒドロキ
ノン(hydroquinone)系列の化合物はメラニン生合成を
阻害する美白用クリームに開発され使用されてきたが、
細胞毒性による皮膚刺激または皮膚病を誘発するものと
知られていて現在一部国家のみ使用が許可されている実
情である。したがって、予め安定性が立証されている天
然物を利用してチロシナーゼ阻害物質を選別しようとす
る試みがなされている。
2. Description of the Related Art Melanin is a phenolic biopolymer having a complex form of black pigment and protein, and is a browning or animal produced when apple, potato and banana cut surfaces are exposed to air. Hull,
It can be observed from wings, skin, hair, eyes, etc. However, when melanin is overproduced, spots, freckles, etc. are formed on the skin, promoting skin aging and inducing skin cancer, and deteriorating the quality of vegetables, fruits, and fresh foods. There is also action. It has been reported that melanin is biosynthesized mainly by the action of tyrosinase. Tyrosinase is an enzyme linked to copper (Cu) and is widely distributed in animals, plants, microorganisms, humans, etc., and is monohydroxy or dihydroxy-phenylalanine (DOPA).
Promotes aerobic oxidation with phenyl compounds such as melamine toose (melanint)
orth), causing skin aging or damage. Also, in vegetables or fruits, polyphenol oxidase such as tyrosinase (polyphen
ol oxidase) causes browning development of the food. Animal melanin whose production is catalyzed by tyrosinase is classified into yellow-reddish brown pheomelanin and brown-black eumelanin. In the process of synthesizing melanin, L-tyrosine is hydroxylated from L-tyrosine to L-3,4-dihydroxy-phenylalanine (DOPA, L-3,4-dihydroxy-phenylalanine) in accordance with the degree of tyrosinase activity, and furthermore, dopaquinone is obtained from DOPA.
one) and dopaquinone is converted to leucochrome (le
ucochrome), the oxidation of leucochrome produces dopachrome, and dopachrome is further converted to 5,6-dihydroxyindole (DHI, 5,
6-dihydroxyindole), and this dihydroxyindole is polymerized oxidatively and is finally bound to the protein. In addition to the pathway in which dopachrome is converted to DHI, dopachrome tautomerase acts in the body to allow 5,6-dihydroxyindolecarboxylate (DHICA, 5,6-dihyd).
It has also been reported that there is a new pathway for conversion to droxyindole carboxylic acid). The biosynthetic metabolism of melanin has been intensively studied recently in connection with skin cancer, and various melanin production inhibitors have been developed to prevent skin diseases in the pharmaceutical industry, and to prevent spots and freckles in the cosmetics industry. And it is applied as a skin whitening agent to be treated or an anti-browning agent in the food industry. In recent years, the demand for environmental problems has been increasing rapidly. Until now, research on melanogenesis inhibitors has been focused mainly on the development of tyrosinase inhibitors, and typical tyrosinase inhibitors are based on quinones, which are chelating substances for copper ions in the tyrosinase active site. And reducing agents such as ascorbic acid to reduce tyrosinase itself, and bisulfites preparations to modify tyrosinase itself. As described above, tyrosinase inhibitors have been developed as various whitening agents and are currently used, but various problems have been raised at the same time. Indeed, 4-hydroxyanisole and hydroquinone (hydroq) have been used locally for the treatment of hyperpigmentation such as spots, freckles, spots and hyperpigmentation during pregnancy.
uinone) and the like have strong melanin production inhibitory activity, but at the same time, have side effects such as inducing denaturation or killing of pigment cells and impairing the original function of the cells. In particular, compounds of the hydroquinone family have been developed and used in whitening creams that inhibit melanin biosynthesis,
It is known to induce skin irritation or skin disease due to cytotoxicity, and is currently only allowed to be used in some countries. Therefore, an attempt has been made to select a tyrosinase inhibitor using a natural product whose stability has been proved in advance.

【0002】[0002]

【発明が解決しようとする課題】本発明の課題は、上記
の試みのひとつとして、チロシナーゼ阻害剤としての葡
萄の種の抽出物及びその多様な用途の提供にある。
One of the objects of the present invention is to provide grape seed extracts as tyrosinase inhibitors and their various uses.

【0003】[0003]

【課題を解決するための手段】これまで、本発明者達は
天然物からメラニン生成を抑制するチロシナーゼ阻害剤
を開発するため研究しているところ、葡萄の種にポリフ
ェノルである縮合タンニン(condensed tanninまたはpr
oanthocyanidin)が多く含有されていて葡萄の種の粉末
を水または有機溶媒で抽出して得た葡萄の種の抽出物が
チロシナーゼ活性を阻害してメラニン生成を効果的に抑
制することを確認することで、本発明を完成した。した
がって、本発明は水または有機溶媒を使用して抽出した
チロシナーゼ阻害活性を有する葡萄の種の抽出物及びそ
の製造方法を提供する。このとき有機溶媒としてはエタ
ノール、メタノールまたはアセトンなどを使用すること
が望ましく、また有機溶媒の濃度は60〜90%範囲に
して熱水条件または加熱条件で葡萄の種の粉末を抽出す
ることが望ましい。また、本発明は前記葡萄の種の抽出
物を有効成分とするメラニン生成抑制、皮膚老化防止、
皮膚保護及び美白機能を有する化粧料を提供する。ま
た、本発明は前記葡萄の種の抽出物を有効成分とするメ
ラニン生成抑制剤用薬学的組成物を提供する。これはシ
ミ、ソバカス、斑点または妊娠期過色素沈着(hyperpig
mentation )の治療に使用されうる。また、本発明は前
記葡萄の種の抽出物を有効成分として果実、野菜及び生
鮮などの食品の褐変を抑制する食品添加物を提供する。
Means for Solving the Problems So far, the present inventors have been studying to develop a tyrosinase inhibitor which suppresses melanin production from natural products, and found that condensed tannin which is a polyphenol is added to grape seeds. Or pr
oanthocyanidin), to confirm that grape seed extract obtained by extracting grape seed powder with water or organic solvent inhibits tyrosinase activity and effectively suppresses melanin production. Thus, the present invention has been completed. Accordingly, the present invention provides an extract of grape seeds having tyrosinase inhibitory activity extracted using water or an organic solvent, and a method for producing the same. At this time, it is desirable to use ethanol, methanol or acetone as the organic solvent, and it is preferable to extract the grape seed powder under hot water or heating conditions with the concentration of the organic solvent in the range of 60 to 90%. . Further, the present invention suppresses melanin production using the extract of the grape seed as an active ingredient, prevents skin aging,
Provided is a cosmetic having a skin protection and whitening function. The present invention also provides a pharmaceutical composition for a melanin production inhibitor comprising an extract of the grape seed as an active ingredient. This can be caused by spots, freckles, spots or gestational hyperpigmentation (hyperpig
mentation). The present invention also provides a food additive which suppresses browning of foods such as fruits, vegetables and fresh foods using the extract of the grape seed as an active ingredient.

【0004】[0004]

【発明の実施の形態】以下、本発明をさらに詳細に説明
する。本発明はチロシナーゼ阻害活性を有する葡萄の種
の抽出物を製造するために脂肪を除去した葡萄の種の粉
末を水と有機溶媒などを使用して多様な温度で抽出す
る。望ましくは、抽出溶媒と温度による乾燥収率とポリ
フェノル含量を考慮するとき、熱水抽出条件で60〜9
0%アセトンを使用したり加熱条件で60〜90%エタ
ノールまたは60〜90%メタノールを使用して葡萄の
種の抽出物を製造し、より好ましくは熱水抽出条件で7
0〜80%アセトンを使用したり加熱条件で70〜80
%エタノールまたは70〜80%メタノールを使用して
葡萄の種の抽出物を製造する。前記葡萄の種の抽出物の
チロシナーゼ阻害活性をキノコのチロシナーゼなどをL
−ジヒドロキシフェニルアラニン(L−DOPA)などと反
応させ測定した吸光度から調査した結果、前記葡萄の種
の抽出物は既存のコウジ酸(kojic acid)、ヒドロキノ
ン(hydroquinone)、アルブチン(arbutin )、4−ヒ
ドロキシアニソール(4−hydroxyanisole)、アスコル
ビン酸(ascorbic acid )、レチノール(retinol )、
ヒドロコチソン(hydrocortison )よりチロシナーゼ阻
害活性が優れているものと示された(図1参照)。特に
ポリフェノール含量が高い70〜80%アセトンを用い
て得た葡萄の種の抽出物が望ましい前記阻害活性を示
す。また、前記葡萄の種の抽出物のメラニン生合成阻害
活性度メラニンを生合成する微生物であるストレプトマ
イセスビキニエンシス(Streptomyces bikiniensis)菌
株などを用いて調査する(図2参照)。このときメラニ
ン生成阻害環(Inhibition zone,mm)の大きさを測定し
た結果、前記葡萄の種の抽出物はコウジ酸、ヒドロキノ
ン、アルブチン、4−ヒドロアニソールより比較的に大
きくきれいな阻害環を生成させた。
BEST MODE FOR CARRYING OUT THE INVENTION Hereinafter, the present invention will be described in more detail. According to the present invention, fat-free grape seed powder is extracted at various temperatures using water and an organic solvent to prepare a grape seed extract having tyrosinase inhibitory activity. Preferably, when the drying yield and the polyphenol content depending on the extraction solvent and the temperature are taken into consideration, the hot water extraction condition is 60 to 9%.
A grape seed extract is prepared using 0% acetone or 60-90% ethanol or 60-90% methanol under heating conditions, and more preferably under hot water extraction conditions.
Use 0-80% acetone or 70-80% under heating conditions.
A grape seed extract is prepared using% ethanol or 70-80% methanol. The tyrosinase inhibitory activity of the grape seed extract may be determined by adding mushroom tyrosinase or the like.
As a result of investigating the absorbance measured by reacting with dihydroxyphenylalanine (L-DOPA) or the like, the extract of the grape seeds was found to contain the existing kojic acid, hydroquinone, arbutin, and 4-hydroxy. Anisole (4-hydroxyanisole), ascorbic acid (ascorbic acid), retinol (retinol),
It was shown that tyrosinase inhibitory activity was superior to hydrocortison (see FIG. 1). In particular, grape seed extract obtained using 70-80% acetone having a high polyphenol content exhibits the desired inhibitory activity. The melanin biosynthesis inhibitory activity of the grape seed extract is also investigated using Streptomyces bikiniensis, which is a microorganism that biosynthesizes melanin (see FIG. 2). At this time, as a result of measuring the size of the melanin formation inhibition ring (Inhibition zone, mm), the grape seed extract produced a relatively large and beautiful inhibition ring than kojic acid, hydroquinone, arbutin and 4-hydroanisole. Was.

【0005】したがって、前記葡萄の種の抽出物はチロ
シナーゼ活性を阻害するメラニン生成抑制剤としてシ
ミ、ソバカス、斑点または妊娠期過色素沈着(hyperpig
mentation )などの予防及び治療に使用することができ
る。また、前記葡萄の種の抽出物はメラニン生成抑制、
皮膚老化防止、皮膚保護または美白機能を有する化粧料
としても使用され柔軟化粧水、栄養化粧水、栄養クリー
ム、マッサージクリーム、エッセンス、パックなどに添
加することができる(図3参照)。また、前記葡萄の種
の抽出物は果物、野菜及び生鮮などの食品の褐変を抑制
して新鮮度を高める食品添加剤として使用することがで
きる。
Accordingly, the extract of the grape seed is used as an inhibitor of melanin production that inhibits tyrosinase activity, such as spots, freckles, spots or hyperpigmentation during pregnancy.
mentation) and the like. Also, the grape seed extract may inhibit melanin production,
It is also used as a cosmetic having a skin aging prevention, skin protection or whitening function, and can be added to a softening lotion, a nourishing lotion, a nourishing cream, a massage cream, an essence, a pack, etc. (see FIG. 3). In addition, the grape seed extract can be used as a food additive that suppresses browning of foods such as fruits, vegetables, and freshness, and increases freshness.

【0006】前記葡萄の種の抽出物は既に毒性がないこ
とが確認された食用果物の抽出物であり、前記課程を通
じて製造された抽出物が治療用薬剤に利用するために薬
剤学的分野で公知の方法により製造されうるし、その自
体または薬学的に許容される担体(carrier )、浮形剤
(forming agent )、希釈剤(diluent )などと混合し
て軟膏剤、粉末、顆粒、錠剤、カプセル剤または注射剤
などの諸形に製造され用いられる。また、これら非経口
または経口に投与したり皮膚に塗布して使用することが
できる。
[0006] The grape seed extract is an edible fruit extract which has been confirmed to be non-toxic, and the extract produced through the above process is used in the pharmaceutical field to be used as a therapeutic drug. Ointments, powders, granules, tablets, capsules can be manufactured by a known method, or mixed with a pharmaceutically acceptable carrier, a forming agent, a diluent, or the like. It is manufactured and used in various forms such as drugs and injections. In addition, they can be used parenterally or orally or applied to the skin.

【0007】本発明による有効成分の投与量は体内で活
性成分の吸水度、不活性化率、排泄速度、患者の年齢、
性別及び状態、治療する疾病の重症の程度などにしたが
い適切に選択されるが、一般的に成人に一日に5−30
0mg程度を使用するが、25−200mg程度を使用する
のが望ましい。このように諸形化された製剤は必要に応
じて薬剤の投与を監視したり観察する専門家の判断と個
人の要求に従い専門化された投薬法を使用したり、一定
時間間隔で数回投与したり皮膚に塗布することができ
る。
[0007] The dose of the active ingredient according to the present invention is determined by the degree of water absorption, inactivation rate, excretion rate, age of the patient,
It is appropriately selected according to gender and condition, the severity of the disease to be treated, etc., but generally 5-30 days a day for adults.
Although about 0 mg is used, it is desirable to use about 25-200 mg. Formulations formulated in this way can be administered several times at regular intervals, using specialized medications according to expert judgment and individual requirements to monitor and observe drug administration as needed. And can be applied to the skin.

【0008】以下、実施例、製造例及び実験例により本
発明を詳細に説明する。但し、下記実施例、製造例及び
実験例などは本発明を例示するものであり、本発明の内
容がこれら内容により限定されるものではない。以下
で、%は原則として重量%を示す。
Hereinafter, the present invention will be described in detail with reference to Examples, Production Examples and Experimental Examples. However, the following Examples, Production Examples, and Experimental Examples illustrate the present invention, and the contents of the present invention are not limited by these contents. In the following,% indicates weight% in principle.

【0009】<実施例1>葡萄の種の抽出物の製造 葡萄の種を水洗して乾燥させ粉砕機で粉砕してヘキサン
で脂肪を除去したあと、乾燥させて得た葡萄の種の粉末
100gにそれぞれ抽出溶媒で水と温度を異にしたエタ
ノール、メタノールまたはアセトンを0.5〜3L添加
して12時間以下にして各抽出温度にしたがい振湯培養
器(shaking incubator,30度)または温度調節水槽付
き還流抽出機(60〜95℃)で抽出した。次に回転蒸
発機(rotary evaporator)を使用して50℃で前記抽出
物を減圧濃縮させて再び真空乾燥させ粉末状態の葡萄の
種の抽出物(grape seed extract,G .S .E .)を得
た。また、前記抽出溶媒と抽出温度にしたがい抽出前葡
萄の種の重量と抽出のあと乾燥された葡萄の種の粉末の
重量をそれぞれ測定してその対比により乾燥収率を計算
したし、前記葡萄の種のポリフェノ−ル含量はフォリン
−デニス(Follin−Dennis)法により求めた。抽出溶媒
及び抽出温度による葡萄の種の抽出物(G.S.E)の
乾燥収率とポリフェノール含量の関係を見た結果を表1
に示す。前記抽出溶媒と抽出温度による乾燥収率とポリ
フェノ−ル含量を全体的に考慮したとき、熱水抽出条件
で70〜80%アセトンを使用した抽出物と加熱条件で
70〜80%エタノールまたはメタノールを用いた抽出
物がもっとも効果的であることを確認した。
Example 1 Production of Grape Seed Extract Grape seeds were washed with water, dried, crushed with a crusher to remove fat with hexane, and dried to obtain 100 g of grape seed powder. And 0.5 to 3 L of ethanol, methanol or acetone, each having a different temperature from water with an extraction solvent, is added to the mixture for 12 hours or less, and according to each extraction temperature, a shaking incubator (30 ° C.) or temperature control is used. Extraction was performed with a reflux extractor (60 to 95 ° C) equipped with a water tank. Next, the extract was concentrated under reduced pressure at 50 ° C. using a rotary evaporator and dried again under vacuum to obtain a grape seed extract (GSE) in a powder state. Obtained. Also, according to the extraction solvent and the extraction temperature, the weight of the grape seed before extraction and the weight of the grape seed powder dried after the extraction were measured, and the drying yield was calculated based on the measured weight. The polyphenol content of the species was determined by the Follin-Dennis method. Table 1 shows the relationship between the drying yield of the grape seed extract (GSE) and the polyphenol content according to the extraction solvent and the extraction temperature.
Shown in When the drying yield and polyphenol content according to the extraction solvent and the extraction temperature are taken into consideration as a whole, an extract using 70-80% acetone under hot water extraction conditions and 70-80% ethanol or methanol under heating conditions are used. It was confirmed that the extract used was the most effective.

【表1】 [Table 1]

【0010】<実施例2>葡萄の種の抽出物のチロシナ
ーゼ阻害活性調査 前記実施例1で製造した粉末状態の葡萄の種の抽出物の
チロシナーゼ阻害活性を調査するために、キノコのチロ
シナーゼ(mushroom tyrosinase, Sigma, E.C .1 .
14.18.1 )を使用して阻害程度を測定した。このとき
チロシナーゼは1/15M 燐酸緩衝溶液(phosphate bu
ffer, pH6 .8 )に1560units /mL.濃度で溶かし
冷凍庫に凍結保管し、使用時に氷上で溶かし酵素源とし
て利用した。また基質としてはL−3,4−ジヒドロキ
シフェニルアラニン(L−3, 4−dihydroxyphenylalani
ne, L−DOPA)を遮光瓶で1/15M 燐酸緩衝溶液に溶
かして使用し、この溶液を使用直前に調剤した。チロシ
ナーゼ阻害活性はチロシナーゼ(78units /mL)0.
0625mL、1/15M燐酸緩衝溶液1. 4615mLを
一緒に入れ25℃で5分間予め反応(preincubation )
させて、これに前記L−DOPAを0.476mLを入れ47
5nmで10分間吸光度を測定した。即ち、チロシナーゼ
酵素と葡萄の種の溶媒抽出物または分画物を全部入れた
試料群(C)、試料の代わりに同量の1/15M 燐酸緩
衝溶液を入れた対照群(A)、酵素の代わりに1/15
M燐酸緩衝溶液を入れた酵素対照群(D)そして酵素及
び試料の代わりに1/15M燐酸緩衝溶液を入れた空試
験群(B)に分けて実験を遂行した。各群は全部3個ず
つ(triplicate)反復して実験したし、下の数式から酵
素阻害率(%)を算出した。このとき対照群としてはコ
ウジ酸(kojic acid)、ヒドロキノン(hydroquinon
e)、アルブチン(arbutin )、4−ヒドロキシアニソ
ール(4−hydroxyanisole)、アスコルビン酸(ascorb
ic acid )、レチノール(retinol )、ヒドロコチソン
(hydrocortison )を使用した。葡萄の種の抽出物
(G.S.E.)のチロシナーゼ活性に対する阻害度
(%)の関係を見た結果を表2に、対照群のチロシナー
ゼ活性に対する阻害度(%)を表3にそれぞれ示す。チ
ロシナーゼ阻害度(%)は式1で求める。その結果、ポ
リフェノール含量が高かった70〜80%アセトンを使
用した葡萄の種の抽出物と加熱条件で70〜80%エタ
ノール及びメタノールを使用した葡萄の種の抽出物が前
記対照群より高い阻害活性を示した(図1参照)。
Example 2 Investigation of Tyrosinase Inhibitory Activity of Grape Seed Extract In order to investigate the tyrosinase inhibitory activity of the powdery grape seed extract prepared in Example 1, mushroom tyrosinase (mushroom) was used. tyrosinase, Sigma, EC 1.1.
The degree of inhibition was measured using 14.18.1). At this time, tyrosinase was dissolved in a 1/15 M phosphate buffer solution (phosphate buffer).
ffer, pH6. 8) 1560 units / mL. It was thawed at a concentration and stored frozen in a freezer, and thawed on ice for use as an enzyme source at the time of use. As a substrate, L-3,4-dihydroxyphenylalanine (L-3,4-dihydroxyphenylalaniline) is used.
ne, L-DOPA) was dissolved in a 1/15 M phosphate buffer solution in a light-shielding bottle and used, and this solution was dispensed immediately before use. The tyrosinase inhibitory activity was 0.1% tyrosinase (78 units / mL).
Add 0625 mL and 1.4615 mL of 1/15 M phosphate buffer solution together, and pre-incubate at 25 ° C for 5 minutes (preincubation).
Then, 0.476 mL of the L-DOPA was added thereto, and 47
The absorbance was measured at 5 nm for 10 minutes. That is, a sample group (C) containing the tyrosinase enzyme and all the solvent extracts or fractions of grape seeds, a control group (A) containing the same amount of 1/15 M phosphate buffer instead of the sample, 1/15 instead
The experiment was divided into an enzyme control group (D) containing M phosphate buffer solution and a blank test group (B) containing 1 / 15M phosphate buffer solution instead of enzyme and sample. Each group was repeated three times (triplicate), and the enzyme inhibition rate (%) was calculated from the following formula. At this time, kojic acid (kojic acid) and hydroquinone (hydroquinon
e), arbutin, 4-hydroxyanisole, ascorbate (ascorb)
ic acid), retinol and hydrocortison. Table 2 shows the results of the relationship between the degree of inhibition (%) of the grape seed extract (GSE) on tyrosinase activity, and Table 3 shows the degree of inhibition (%) on the tyrosinase activity of the control group. Show. The degree of tyrosinase inhibition (%) is determined by Equation 1. As a result, the grape seed extract using 70-80% acetone having high polyphenol content and the grape seed extract using 70-80% ethanol and methanol under heating conditions had higher inhibitory activities than the control group. (See FIG. 1).

【式1】 A:試料のない対照群の475nmからの吸光度; B:試料と酵素のない対照群の475nmからの吸光度; C:試料と酵素を入れた実験群の475nmからの吸光
度; D:酵素のない対照群の475nmからの吸光度;
(Equation 1) A: Absorbance from 475 nm of control group without sample; B: Absorbance from 475 nm of control group without sample and enzyme; C: Absorbance from 475 nm of experimental group containing sample and enzyme; D: Control without enzyme Absorbance of the group from 475 nm;

【表2】 [Table 2]

【表3】 [Table 3]

【0011】<実施例3>葡萄の種の抽出物のメラニン
生合成阻害活性調査 前記実施例1で製造した粉末状態の葡萄の種の抽出物の
メラニン生合成阻害活性を調査するために、メラニン生
合成微生物であるストレプトマイセスビキニエンシスB
−1049(Streptomyces bikiniensis NRRL B −1
049)を使用した。具体的に前記ストレプトマイセス
ビキニエンシス菌株をV−8ジュース(Cambell Soup C
o., USA )200mL、葡萄糖(glucose )2g 、酵母抽
出物(yeast extract )2g 、 CaCO31g 、バクトアガ
2g と蒸留水800mLを含有するpH7.2のパパビザス
VDYA(Papavizas ′VDYA(15))斜面培地に接種し、
これを28℃で2週間培養したあと、前記斜面培地表面
に2mLの蒸留水を加えて既菌糸に形成された胞子をルー
プ(loop)で掻き出して胞子乳沢液を作ったあと、この
胞子乳沢液を滅菌試験管に冷凍保管した。また、葡萄糖
1.5%、L −チロシン0.05%、L −アスパラジン
0.1%、K2HPO4 0.05%、MgSO4 ・7H2O 0.0
5%、NaCl 0.05%、FeSO4・7H2O 0.001
%、バクトアガ2%を含有するチロシンアガ(ISP No.
7 )培地組成にバクト酵母抽出物(Bacto −yeast ext
ract)を0.2%に添加して個体培地を作って滅菌して
ペトリザラ(90mm i.d .)当40mLに分株した。こ
のように制作したアガプレートに各プレート当0.4mL
の前記S .bikiniensis 胞子乳沢液を加えてガラスホッ
キバー(glass hockey bar )で均一に塗布した。次に
培地表面を乾燥させてこれに50μL の試料を濡らした
8mm直径の紙ディスク(paper disc, 、Toyo Roshi Kas
ha Ltd.,Japan )を載せて28℃条件で48時間培養
してメラニン生成阻害環(inhibition zone 、mm)が生
成するようにした。このメラニン生成阻害環の大きさは
培地の背面から計測したし、このとき対照群としてはコ
ウジ酸、ヒドロキノン、アルブチン、4−ヒドロアニソ
ールを使用した。ストレプトマイセスビキニエンシス菌
株から葡萄の種の抽出物のメラニン生合成に対する阻害
度の関係を表4に、対照群のストレプトマイセスビキニ
エンシスのメラニン生合成に対する阻害度の関係を表5
にそれぞれ示す。その結果、熱水抽出物、70〜80%
アセトンの葡萄の種の抽出物、加熱条件においての70
〜80%エタノールまたはメタノールの葡萄の種の抽出
物から阻害環が比較的に大きくて綺麗に示されていた
(図2参照)。
<Example 3> Investigation of melanin biosynthesis inhibitory activity of grape seed extract The melanin biosynthesis inhibitory activity of the powdery grape seed extract prepared in Example 1 was investigated. Streptomyces bikiniensis B, a biosynthetic microorganism
-1049 (Streptomyces bikiniensis NRRL B-1
049) was used. Specifically, the Streptomyces bikiniensis strain was used in V-8 juice (Cambell Soup C).
o., USA) 200 mL of glucose, 2 g of glucose, 2 g of yeast extract, 1 g of CaCO 3 , 2 g of Bacto agar and 800 mL of distilled water at a pH 7.2 Papavizas
VDYA (Papavizas'VDYA (15))
After culturing this at 28 ° C. for 2 weeks, 2 mL of distilled water was added to the surface of the slant medium, and spores formed in the mycelia were scraped out with a loop to produce a spore milk solution. The liquid was stored frozen in a sterile test tube. Further, glucose 1.5%, L - 0.05% tyrosine, L - asparagus Jin 0.1%, K 2 HPO 4 0.05 %, MgSO 4 · 7H 2 O 0.0
5%, 0.05% NaCl, FeSO 4 · 7H 2 O 0.001
%, 2% Bacto-aga (ISP No.
7) Bacto-yeast ext
ract) was added to 0.2% to prepare a solid medium, sterilized, and then separated into 40 mL per Petrizara (90 mm id). 0.4 mL per plate for the agar plate thus produced
Said S. Bikiniensis spore milk solution was added, and the mixture was uniformly applied with a glass hockey bar. Next, the surface of the culture medium was dried, and a 50-μL sample was wetted with an 8 mm diameter paper disc (paper disc, Toyo Roshi Kas).
ha Ltd. , Japan) and cultured at 28 ° C. for 48 hours to form a melanin production inhibition ring (inhibition zone, mm). The size of the melanin production-inhibiting ring was measured from the back of the medium, and at this time, kojic acid, hydroquinone, arbutin, and 4-hydroanisole were used as control groups. Table 4 shows the relationship between the degree of inhibition of melanin biosynthesis of extracts of grape seeds from Streptomyces bikiniensis strains, and Table 5 shows the relationship between the degree of inhibition of melanin biosynthesis of Streptomyces bikiniensis in the control group.
Are shown below. As a result, hot water extract, 70-80%
Grape seed extract of acetone, 70% under heating conditions
Grape seed extracts of 〜80% ethanol or methanol showed relatively large and clear inhibitory rings (see FIG. 2).

【表4】 [Table 4]

【表5】 [Table 5]

【0012】<製造例1>葡萄の種の抽出物を含有した
化粧料のうち柔軟化粧水処方例は次の通りである。ここ
で葡萄の種の抽出物は実施例1から得た加熱条件の75
%エタノール抽出物を使用した。 重量部 重量部 葡萄の種の抽出物 0.01、 グリセリン 3.0、 ブチレングリコール 2.0 プロピレングリコール 2.0 カルボキシビニルポリマー 0.1 エタノール 10.0 トリエタノールアミン 0.1 防腐剤 微量 色素 微量 香料 微量 精製水 残液 計 100.0
<Production Example 1> Among cosmetics containing an extract of grape seeds, an example of formulating a soft lotion is as follows. Here, the grape seed extract was used under the heating condition of 75 obtained from Example 1.
% Ethanol extract was used. Parts by weight parts by weight grape seed extract 0.01, glycerin 3.0, butylene glycol 2.0 propylene glycol 2.0 carboxyvinyl polymer 0.1 ethanol 10.0 triethanolamine 0.1 preservative trace pigment trace Perfume trace amount Purified water Residual liquid Total 100.0

【0013】<製造例2>葡萄の種の抽出物を含有した
化粧料のうち栄養化粧水処方例は次の通りである。ここ
で葡萄の種の抽出物は前記製造例と同一である。 重量部 重量部 葡萄の種の抽出物 0.01 蜜蝋 4.0 ポリソルベート60 1.5 ソルビタンセスキオレート 0.5 流動パラフィン 5.0 スクアラン 5.0 カプリル酸/カプリルトリグリセライド 5.0 グリセリン 3.0 ブチレングリコール 3.0 プロピレングリコール 3.0 カルボキシビニルポリマー 0.1 トリエタノールアミン 0.2 防腐剤 微量 色素 微量 香料 微量 精製水 残液 計 100.0
<Production Example 2> Among cosmetics containing an extract of grape seeds, an example of a nutritional lotion formulation is as follows. Here, the grape seed extract is the same as in the above preparation example. Parts by weight Parts by weight Grape seed extract 0.01 Beeswax 4.0 Polysorbate 60 1.5 Sorbitan sesquiolate 0.5 Liquid paraffin 5.0 Squalane 5.0 Caprylic acid / capryl triglyceride 5.0 Glycerin 3.0 Butylene Glycol 3.0 Propylene glycol 3.0 Carboxyvinyl polymer 0.1 Triethanolamine 0.2 Preservatives Trace dyes Trace fragrance Traces purified water Residual liquid Total 100.0

【0014】<製造例3>葡萄の種の抽出物を含有した
化粧料のうち栄養クリーム処方例は次の通りである。こ
こで葡萄の種の抽出物は前記製造例と同一である。 重量部 重量部 葡萄の種の抽出物 0.005 蜜蝋 10.0 ポリソルベート60 1.5 ソルビタンセスキオレート 0.5 流動パラフィン 10.0 スクアラン 5.0 カプリル酸/カプリルトリグリセライド 5.0 グリセリン 5.0 ブチレングリコール 3.0 プロピレングリコール 3.0 トリエタノールアミン 0.2 防腐剤 微量 色素 微量 香料 微量 精製水 残液 計 100.0
<Production Example 3> Formulation examples of a nutritional cream among cosmetics containing an extract of grape seeds are as follows. Here, the grape seed extract is the same as in the above preparation example. Parts by weight grape seed extract 0.005 beeswax 10.0 polysorbate 60 1.5 sorbitan sesquiolate 0.5 liquid paraffin 10.0 squalane 5.0 caprylic acid / caprylic triglyceride 5.0 glycerin 5.0 butylene Glycol 3.0 Propylene glycol 3.0 Triethanolamine 0.2 Preservative trace amount pigment trace amount fragrance trace amount purified water residual liquid total 100.0

【0015】<製造例4>葡萄の種の抽出物を含有した
化粧料のうちマッサージクリーム処方例は次のりであ
る。ここで葡萄の種の抽出物は前記製造例と同一であ
る。 重量部 重量部 葡萄の種の抽出物 0.005 蜜蝋 10.0 ポリソルベート60 0.8 ソルビタンセスキオレート 0.5 流動パラフィン 40.0 スクアラン 5.0 カプリル酸/カプリルトリグリセライド 4.0 グリセリン 5.0 ブチレングリコール 3.0 プロピレングリコール 3.0 トリエタノールアミン 0.2 防腐剤 微量 色素 微量 香料 微量 精製水 残液 計 100.0
<Production Example 4> Among cosmetics containing grape seed extract, an example of a massage cream formulation is as follows. Here, the grape seed extract is the same as in the above preparation example. Parts by weight grape seed extract 0.005 beeswax 10.0 polysorbate 60 0.8 sorbitan sesquiolate 0.5 liquid paraffin 40.0 squalane 5.0 caprylic acid / caprylic triglyceride 4.0 glycerin 5.0 butylene Glycol 3.0 Propylene glycol 3.0 Triethanolamine 0.2 Preservative trace amount pigment trace amount fragrance trace amount purified water residual liquid total 100.0

【0016】<製造例5>葡萄の種の抽出物を含有した
化粧料のうちパックの処方例は次の通りである。ここで
葡萄の種の抽出物は前記製造例と同一である。 重量部 重量部 葡萄の種の抽出物 0.005 ポリビニルアルコール 13.0 ソディウムカルボキシメチルセルロス 0.2 アラントイン 0.1 ノニルフェニルエーテル 0.3 防腐剤 微量 色素 微量 香料 微量 精製水 残液 計 100.0
<Production Example 5> Among cosmetics containing an extract of grape seeds, a formulation example of a pack is as follows. Here, the grape seed extract is the same as in the above preparation example. Parts by weight grape seed extract 0.005 polyvinyl alcohol 13.0 sodium carboxymethylcellulose 0.2 allantoin 0.1 nonylphenyl ether 0.3 preservatives trace pigment trace fragrance trace purified water residual liquid Total 100. 0

【0017】<実験例1>皮膚の色素沈着抑制 健康な男女20人の実験対象者の両腕の下膊部に2×2
cm2 の部位を設定した。実験対象部位のみ紫外線が照射
されるようにアルミニウムホイルを腕に被せ10cm距離
で日本トウシバ(株)制FL20S BLB ランプ及びFL20S E
−30ランプを各2個同時に0.8×107erg/cm3 /回
で一日一回ずつ連続3回照射した。照射前に実験対象部
位を70%イソプロピルアルコール水溶液によく洗滌し
た。照射のあと紫外線照射部位に葡萄の種の抽出物を含
有した製造例1〜5の処方を一日3回ずつ塗布した。3
週塗布したあと肉眼で色素沈着度を判定し、実験群(基
剤のみ塗布)に比して色素沈着をいかに抑制したのかを
著しい効果、有効、無効の3段階に評価した。表6で示
した通り有効以上の陽性効果が高く示されることで色素
沈着が卓越して抑制される効果を示した。
<Experimental Example 1> Inhibition of skin pigmentation 2 × 2 in the lower arm of both arms of 20 healthy male and female subjects
A site of cm 2 was set. Put an aluminum foil on your arm so that only the part to be tested is irradiated with ultraviolet rays, and place it at a distance of 10 cm.
Two −30 lamps were simultaneously irradiated at a rate of 0.8 × 10 7 erg / cm 3 / time, once a day, three times continuously. Prior to irradiation, the target site was thoroughly washed with a 70% aqueous isopropyl alcohol solution. After irradiation, the formulations of Production Examples 1 to 5 containing the extract of grape seeds were applied to the ultraviolet irradiation site three times a day. 3
After weekly application, the degree of pigmentation was determined by the naked eye, and how the pigmentation was suppressed compared to the experimental group (only the base was applied) was evaluated in three levels of remarkable effect, effectiveness, and ineffectiveness. As shown in Table 6, the effect of suppressing the pigmentation was shown by showing a positive effect higher than the effective effect.

【表6】 [Table 6]

【0018】[0018]

【発明の効果】上に見た通り、本発明の葡萄の種の抽出
物は天然物から製造したため副作用が全くなく、チロシ
ナーゼ活性を阻害してメラニン生成を卓越して抑制する
ので、皮膚老化防止、皮膚保護及び美白機能を有する化
粧料、シミ、ソバカス、斑点または妊娠期過色素沈着
(hyperpigmentation )などの過剰色素症治療剤及び食
品の褐変を抑制する食品添加剤などに有用である。
As can be seen from the above, the grape seed extract of the present invention has no side effects since it is manufactured from natural products, and inhibits tyrosinase activity and suppresses melanin production, thus preventing skin aging. It is useful for cosmetics having skin protection and whitening functions, for treating hyperpigmentation such as spots, freckles, spots or hyperpigmentation during pregnancy, and as food additives for suppressing browning of foods.

【図面の簡単な説明】[Brief description of the drawings]

【図1】 発明の葡萄の種の抽出物と既存ヒドロキノン
のチロシナーゼ阻害活性を濃度によって比較して示した
グラフであり、図中の符号は下記を意味する。 ◆:70%エタノール抽出物(30℃); ■:70%アセトン抽出物; △:ヒドロキノン; ●:熱水抽出物; □:70%エタノール(90℃); ○:70%メタノール(90℃);
FIG. 1 is a graph showing the tyrosinase inhibitory activities of grape seed extract of the present invention and existing hydroquinone according to concentration, and the symbols in the figure mean the following. ◆: 70% ethanol extract (30 ° C.); ■: 70% acetone extract; Δ: hydroquinone; ●: hot water extract; □: 70% ethanol (90 ° C.); ○: 70% methanol (90 ° C.) ;

【図2】 本発明の葡萄の種の抽出物のメラニン生合成
の阻害程度をストレプトマイセスビキニエンシス(Stre
ptomyces bikinienis )菌株を使用して照射した結果を
示す写真。
FIG. 2 shows the degree of inhibition of melanin biosynthesis of the grape seed extract of the present invention.
(ptomyces bikinienis) A photograph showing the results of irradiation using a strain.

【図3】 本発明の葡萄の種の抽出物のソバカス及びシ
ミの治療効果を使用前及び使用後(16週経過)に分け
て示す写真。
FIG. 3 is a photograph showing the therapeutic effect of the grape seed extract of the present invention on freckles and spots before and after use (after 16 weeks).

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI テーマコート゛(参考) A61K 7/00 A61K 7/00 W U 7/48 7/48 31/00 617 31/00 617 C12N 9/99 C12N 9/99 (71)出願人 596065337 108−2,5−Ka,Yangpyung −Dong,Youngdeungpo− ku,Seoul,Korea. (72)発明者 リー,スン−ジェ 大韓民国,キョンキ−ド 422−240,プチ ョン−シ,ソサ−ク,シムゴクボン−ドン 566−1,プチョン エーピーティー. #7−205 (72)発明者 ジャン,ジェ−クウォン 大韓民国,ソウル 138−190,ソンパ− ク,ソクチョン−ドン 229−8,ジェウ ォン ヴィラ #102 (72)発明者 パク,シ−ヨン 大韓民国,ソウル 143−224,クウァンジ ン−ク,ジューンコク 4−ドン 81−10 (72)発明者 リー,ヒュン−クク 大韓民国,ソウル 139−210,ノウォン− ク,サンケ 10−ドン,ズーコン エーピ ーティー.#711−708──────────────────────────────────────────────────続 き Continued on the front page (51) Int.Cl. 7 Identification symbol FI Theme coat ゛ (Reference) A61K 7/00 A61K 7/00 W U 7/48 7/48 31/00 617 31/00 617 C12N 9 / 99 C12N 9/99 (71) Applicant 596065337 108-2,5-Ka, Yangpyung-Dong, Youngdeungpo-ku, Seoul, Korea. (72) Inventor Lee, Sun-Jae, Republic of Korea, Gyeonggi-do 422-240, # 7-205 (72) Inventor Jean, Jae-Kwon South Korea, Seoul 138-190, Songpaak, Sokchon-dong 229 −8, Jaewon Villa # 102 (72) Inventors Park, Chillon, Republic of Korea, SO Le 143-224, Kuwanji down - click, Junkoku 4- Don 81-10 (72) inventor Lee, Hyun - Amblyseius Korea, Seoul 139-210, Nowon - click, gas production 10 Don, Zukon Epi Ti. # 711-708

Claims (6)

【特許請求の範囲】[Claims] 【請求項1】水および/または有機溶媒を使用して抽出
したチロシナーゼの阻害活性を有する葡萄の種の抽出
物。
1. A grape seed extract having tyrosinase inhibitory activity, extracted using water and / or an organic solvent.
【請求項2】前記抽出は、有機溶媒としてエタノール、
メタノールおよびアセトンのうちの少なくとも1種が使
用され、 60〜90%濃度範囲の有機溶媒で熱水条件
または加熱条件で葡萄の種の粉末から行われている、第
1項記載の葡萄の種の抽出物。
2. The extraction comprises ethanol as an organic solvent,
2. The grape seed according to claim 1, wherein at least one of methanol and acetone is used, and the grape seed powder is obtained from a grape seed powder under a hydrothermal condition or a heating condition in an organic solvent in a concentration range of 60 to 90%. Extract.
【請求項3】メラニン生成抑制、皮膚老化の防止、皮膚
保護及び美白機能を有する、第1項または第2項記載の
葡萄の種の抽出物を有効成分とする化粧料。
3. A cosmetic composition comprising the grape seed extract according to claim 1 or 2 as an active ingredient, which has a melanin production-inhibiting, skin aging-preventing, skin-protecting and whitening function.
【請求項4】第1項または第2項記載の葡萄の種の抽出
物を有効成分とする、メラニン生成抑制剤用の薬学的組
成物。
4. A pharmaceutical composition for a melanogenesis inhibitor, comprising the grape seed extract according to claim 1 or 2 as an active ingredient.
【請求項5】シミ、ソバカス、斑点または妊娠期過色素
沈着(hyperpigmentation )を包含する過剰色素症の治
療に使用する、第4項記載の薬学的組成物。
5. The pharmaceutical composition according to claim 4, for use in the treatment of hyperpigmentation, including spots, freckles, spots or hyperpigmentation during pregnancy.
【請求項6】第1項または第2項記載の葡萄の種を抽出
物を有効成分とする、果物、野菜および生鮮品を包含す
る食品の褐変を抑制する食品添加物。 【0001】
6. A food additive which suppresses browning of foods, including fruits, vegetables and fresh products, comprising a grape seed according to claim 1 or 2 as an extract. [0001]
JP11124735A 1998-11-27 1999-04-30 Extract from grape seed and its use Pending JP2000159681A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1019980051189A KR20000034037A (en) 1998-11-27 1998-11-27 Grape seed extract as tyrosinase inhibitor
KR1998-51189 1998-11-27

Publications (1)

Publication Number Publication Date
JP2000159681A true JP2000159681A (en) 2000-06-13

Family

ID=19559987

Family Applications (1)

Application Number Title Priority Date Filing Date
JP11124735A Pending JP2000159681A (en) 1998-11-27 1999-04-30 Extract from grape seed and its use

Country Status (3)

Country Link
JP (1) JP2000159681A (en)
KR (1) KR20000034037A (en)
CN (1) CN1255357A (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2172475A1 (en) * 2001-03-02 2002-09-16 Raoulj Hermitte Set of cosmetics obtained from vitis plants and alpha hydroxy acids cosnists of blends incorporating egg fractions, wine and vine leaf
JP2003532644A (en) * 2000-04-28 2003-11-05 ロレアル Plant extracts of Vitis vinifera species as NO synthase inhibitors and their use
US7875302B2 (en) 2004-12-14 2011-01-25 Access Business Group International Llc Methods of using grape seed extract to stimulate tyrosinase gene expression
US7955628B2 (en) 2004-12-14 2011-06-07 Access Business Group International Llc Methods of using nonpolar grape seed extracts to stimulate tyrosinase expression or melanin synthesis
JP2014162726A (en) * 2013-02-21 2014-09-08 Unitika Ltd Functional compositions
CN107007792A (en) * 2017-04-27 2017-08-04 福建省康馨生物科技有限公司 A kind of pharmaceutical composition of nti-freckle and preparation method thereof, preparation and application
JP2020093999A (en) * 2018-12-12 2020-06-18 花王株式会社 1-phenyl-2-phenylethane derivative
WO2022171292A1 (en) 2021-02-12 2022-08-18 Symrise Ag Medicament for prevention and treatment of hyperpigmentation

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1111068C (en) * 2000-07-27 2003-06-11 上海北医大生物科技有限公司 Strong anti-oxidative composite capsule of grape seed extract OPC and its producing method
KR100409041B1 (en) * 2001-03-09 2003-12-18 학교법인 청강학원 Rice coated with fat-removed grape seed extracts
KR20030023172A (en) * 2001-09-12 2003-03-19 주식회사 퓨쳐바이오테크 fruit bioactive component and extrating process thereof
KR100830403B1 (en) * 2006-09-28 2008-05-20 라호열 Natural cosmetic composition having the cactus fermented liquid and grape seed extracts
KR100854116B1 (en) * 2007-03-20 2008-08-26 주식회사 케이티앤지 Composition for skin whitening comprising extracts of torilis japonica
US20100068259A1 (en) * 2008-05-30 2010-03-18 Annette Tobia Natural product inhibitors of 3dg
SG186804A1 (en) * 2010-06-30 2013-02-28 Nestec Sa Use of caftaric acid and derivatives in food supplement for regulating skin pigmentation
US20150272863A1 (en) * 2014-03-25 2015-10-01 Active Concepts, LLC H3 antagonist by-product, its manufacture, and method of using by-product to reduce pigmentation in skin
KR102036532B1 (en) * 2015-04-09 2019-10-25 아이에스피 인베스트먼츠 엘엘씨 Cosmetic treatment methods to protect skin from contamination and improve skin regeneration
CN113234049B (en) * 2021-04-16 2023-12-22 广州纳丽生物科技有限公司 Tyrosinase inhibitor based on grape seed extraction and extraction method and application thereof

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003532644A (en) * 2000-04-28 2003-11-05 ロレアル Plant extracts of Vitis vinifera species as NO synthase inhibitors and their use
ES2172475A1 (en) * 2001-03-02 2002-09-16 Raoulj Hermitte Set of cosmetics obtained from vitis plants and alpha hydroxy acids cosnists of blends incorporating egg fractions, wine and vine leaf
US7875302B2 (en) 2004-12-14 2011-01-25 Access Business Group International Llc Methods of using grape seed extract to stimulate tyrosinase gene expression
US7955628B2 (en) 2004-12-14 2011-06-07 Access Business Group International Llc Methods of using nonpolar grape seed extracts to stimulate tyrosinase expression or melanin synthesis
JP2014162726A (en) * 2013-02-21 2014-09-08 Unitika Ltd Functional compositions
CN107007792A (en) * 2017-04-27 2017-08-04 福建省康馨生物科技有限公司 A kind of pharmaceutical composition of nti-freckle and preparation method thereof, preparation and application
JP2020093999A (en) * 2018-12-12 2020-06-18 花王株式会社 1-phenyl-2-phenylethane derivative
JP7239310B2 (en) 2018-12-12 2023-03-14 花王株式会社 1-phenyl-2-phenylethane derivative
WO2022171292A1 (en) 2021-02-12 2022-08-18 Symrise Ag Medicament for prevention and treatment of hyperpigmentation

Also Published As

Publication number Publication date
CN1255357A (en) 2000-06-07
KR20000034037A (en) 2000-06-15

Similar Documents

Publication Publication Date Title
KR101997893B1 (en) Method of increase the bioactive effectiveness of sprout ginseng
JP2000159681A (en) Extract from grape seed and its use
KR20090088894A (en) Extract powder of indigo-containing plant, method for production thereof, and use thereof
KR20190117082A (en) Composition for anti-oxidation, anti-inflammation, anti-diabetes, whitening, anti-wrinkle, or anti-gout comprising extract of Rubies apple peel
KR102024628B1 (en) Composition for skin whitening or preventing hair loss containing germinated soybean extract
KR20010017516A (en) New Melanin Biosynthesis Inhibitors
EP2123290A1 (en) Melanogenesis inhibitory composition
JP6235779B2 (en) Folic acid-containing composition and method for stabilizing folic acid
CN115025129B (en) Composition containing lactobacillus and use thereof for preventing and/or improving skin aging
KR102299277B1 (en) Composition for improving scalp condition comprising flower extract of passiflora edulis
KR100802005B1 (en) Melanin Biosynthesis Inhibitors which using of ginsenosides
KR101721022B1 (en) Composition for comprising adipic acid for improving skin wrinkle or enhancing skin elasticity
TWI693077B (en) Use of a gooseberry (ribes grossularia) extract and glutathione in manufacturing a composition for skin whitening, inhibiting melanin production or reducing melanin, and inhibiting pigmentation
KR102212343B1 (en) Composition for skin anti-aging or moisturization comprising extract of marian plum
JP2012136447A (en) Lipase inhibitor, and cosmetic, food/drink composition and pharmaceutical composition each containing the same
KR100756669B1 (en) Cosmetic composition comprising an extract of Persicae fructus having whitening activities
KR20010084402A (en) Safflower Seeds Extracts Inhibiting Melanin Biosynthesis and Composition Comprising Same
CN107073056B (en) Composition containing Artemisia alpina extract
KR102334191B1 (en) Functional cosmetic composition comprising potato
KR102579105B1 (en) Compositions for skin whitening, UV protection, and anti skin cancer through enzymatic conversion of Luffa aegyptiaca extracts using probioticst
KR102274305B1 (en) Composition for improving scalp condition comprising flower extract of passiflora laurifolia
KR102291441B1 (en) Composition for skin whitening comprising plum seed extract
KR102612332B1 (en) Compositions for skin whitening and anti-wrinkle containing fermented moringa extract
JP2004147574A (en) Method for culturing wood-decaying fungus and method for using the fungus
KR20120113459A (en) Compositions for skin whitening comprising essential oils from artemisia, lemon and fennel